Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy

INTRODUCTION: The Residual Cancer Burden (RCB) quantifies residual disease after neoadjuvant chemotherapy (NAC). Its predictive value has not been validated on large cohorts with long-term follow up. The objective of this work is to independently evaluate the prognostic value of the RCB index depend...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:PLoS One
Glavni autori: Hamy, Anne-Sophie, Darrigues, Lauren, Laas, Enora, De Croze, Diane, Topciu, Lucian, Lam, Giang-Thanh, Evrevin, Clemence, Rozette, Sonia, Laot, Lucie, Lerebours, Florence, Pierga, Jean-Yves, Osdoit, Marie, Faron, Matthieu, Feron, Jean-Guillaume, Laé, Marick, Reyal, Fabien
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2020
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313974/
https://ncbi.nlm.nih.gov/pubmed/32579551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234191
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items